Crohn's disease management after intestinal resection: a randomised trial.
about
Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's diseaseOptimal delivery of follow-up care after surgery for Crohn's disease: current perspectivesRelevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseasesOptimizing biologic treatment in IBD: objective measures, but when, how and how often?Current role of capsule endoscopy in Crohn's diseasePan-intestinal capsule endoscopy in patients with postoperative Crohn's disease: a pilot study.The use of ultrasound in inflammatory bowel diseaseOptimal diagnosis and disease activity monitoring of intestinal Behçet's diseaseLong-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea.Clinical efficacy of adalimumab in Crohn's disease: a real practice observational study in Japan.Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy.A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease.The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosisEarly anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factorsCost-effectiveness of Crohn's disease post-operative careSerial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn's disease: a long-term prospective study.Second Korean guidelines for the management of Crohn's disease.Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence.Video Capsule Endoscopy of the Small Bowel for Monitoring of Crohn's Disease.IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.Optimizing biological therapy in Crohn's disease.Postoperative prophylaxis in Crohn's disease after intestinal resection: a retrospective analysis.Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era".Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers.Outcome of Surgery for Coloduodenal Fistula in Crohn's Disease.How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and Trials.Management of post-operative Crohn's disease in 2017: where do we go from here?Endoscopic evaluation in diagnosis and management of inflammatory bowel disease.Factors affecting the incidence of early endoscopic recurrence after ileocolonic resection for Crohn's disease: a multicentre observational study.Utility of Biomarkers in the Management of Inflammatory Bowel Disease.Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.Crohn's disease diagnosis, treatment approach, and management paradigm: what the radiologist needs to know.Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.Submucosal Plexitis as a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospective Single-centre Study.Comparison of Fecal Inflammatory Markers in Crohn's Disease.The Presence of Postoperative Infectious Complications is Associated with the Risk of Early Postoperative Clinical Recurrence of Crohn's Disease.Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease.Serologic antibodies in relation to outcome in postoperative Crohn's disease.
P2860
Q24658604-D27312C5-1EA3-4B8C-A3D2-FEC70AAC567DQ26740356-82878683-9E92-489F-B14F-DF6ADE93E0E6Q26750230-E51A18D2-4C05-4590-89BC-342B98425A33Q26775064-CDFFF590-0260-47A4-95FA-FC7FDDC8BD1AQ28071363-37DD4436-5836-4E25-8BAB-1757A4E60EFAQ30313231-FDD921FD-A22A-4E03-B0D9-B24216E626F9Q30362577-601202B8-0964-497D-A743-7E4AA118A670Q33819484-7839DF1F-70A9-455C-9E7F-9F2ABD013C64Q36043775-6774B304-4E9B-473D-B109-5B652883F832Q36089928-CC004D88-8038-46FA-9B78-DA195A648DACQ36215617-CB0A5E8C-FBE8-4FD3-9781-FB1B1296E471Q36230325-E0280F27-6669-4779-8037-4208470D16DEQ36287466-DD2FDD1E-1A9C-4039-B006-AFD643927F3FQ36380315-9533762F-8F5A-4E5C-AD6C-8CD7C50F461FQ36747868-5410ECD8-E689-4852-B30D-66D414971C1AQ37173743-ED94B078-2161-4CDD-84E2-87FD349438D5Q37662498-FCC23592-0964-4C4C-BA27-412588B35B34Q38538894-3A942B7E-FEDF-4B77-BD7A-EDDD2B8E8FE0Q38550833-A9B81746-A9AD-4078-9343-D7CDE607D5BEQ38583688-F68B1848-9755-4044-95D4-15E522604985Q38608158-91334220-12DD-4B36-A2C1-AFF88C7F2B6DQ38608939-4F5BA648-EB0A-43C7-93CB-3A40570ADC53Q38635824-392E9C07-614F-4356-8CA7-9C7B47426412Q38657630-6E2B8D20-4680-49CD-BE43-4ACC12FCFBC1Q38683461-AEE7F50C-BA41-4E4B-A367-8B894F05DB74Q38768496-E77D9B6A-BD1A-4B1B-8BAE-68592B82EB84Q38923621-62C518E2-B874-4AFC-828B-2031A5EACAFAQ38966323-13A6050D-E5BA-4C89-B35B-92AF27E2B6F9Q39064412-60634318-19FD-413D-AEA1-B295EE85B1ACQ39108648-488E58E9-2AE0-49E4-9460-73B8118F3C22Q39110763-14C4C69B-5BB4-49C8-95F9-B5C35EF78310Q39119181-5C98AB15-598A-4807-A09E-349C1F18718BQ39120033-27F5419B-616A-406F-93DB-9FC4109A8C16Q39140194-27645D48-98BC-42E7-827A-8FA29D44E4D7Q39340723-09C9112D-D9E9-4901-B05E-074EA8E82824Q39552158-345DE3E4-8F43-4A2F-A33C-238DF2C8DBCCQ40052049-F7441841-30F6-46E9-9857-E0096DB67C9CQ40211119-00F8B4EC-7F33-4A6B-B3A4-9FF6B62C4531Q40351437-1755E8ED-0C61-49E9-A451-AE6C22145762Q40409129-A78794C9-BA1D-4D45-BFB3-9DDACE0057E7
P2860
Crohn's disease management after intestinal resection: a randomised trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Crohn's disease management after intestinal resection: a randomised trial.
@en
Crohn's disease management after intestinal resection: a randomised trial.
@nl
type
label
Crohn's disease management after intestinal resection: a randomised trial.
@en
Crohn's disease management after intestinal resection: a randomised trial.
@nl
prefLabel
Crohn's disease management after intestinal resection: a randomised trial.
@en
Crohn's disease management after intestinal resection: a randomised trial.
@nl
P2093
P50
P1433
P1476
Crohn's disease management after intestinal resection: a randomised trial.
@en
P2093
Efrosinia O Krejany
Finlay A Macrae
Graham Radford-Smith
Henry Debinski
Ian C Lawrance
Ian Kronborg
Jane M Andrews
Kathryn J Ritchie
Lani Prideaux
Michael A Kamm
P304
P356
10.1016/S0140-6736(14)61908-5
P407
P577
2014-12-24T00:00:00Z